NB

Nitesh Bhanudas Khandekar

Active Director Director DIN 10664444
DIN 10664444 First appointment Jun 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Nitesh Bhanudas Khandekar

Data last updated:

Nitesh Bhanudas Khandekar is a Director at Eridin Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10664444
Primary Designation Director
Industry Pharma
First Appointment 11 Jun 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jun 20242024Active

Board colleagues of Nitesh Bhanudas Khandekar

NameDINCompanyDesignation
Manish Basarkar10664443Eridin Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Eridin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nitesh Bhanudas Khandekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitesh Bhanudas Khandekar

Nitesh Bhanudas Khandekar currently holds 1 directorship: Eridin Pharmaceuticals Private Limited (Director, since 11 Jun 2024).

Nitesh Bhanudas Khandekar was first appointed on 11 Jun 2024 as Director at Eridin Pharmaceuticals Private Limited.

The current boards of Nitesh Bhanudas Khandekar's companies include Manish Basarkar (Eridin Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available